Defense Tech Series C Investors & VC Firms
89 firms in this list, with a median first check of $540K. 27 of them lead rounds. Generated from verified public data and updated continuously.
Fulcrum Venture
Santa MonicaPre-Seed–Growth
18 people
Brookstreet Equity Partners
LondonSeries A–Late Stage
22 people
Balerion Space Ventures
DallasSeed–Late Stage
11 people
ACT Venture Capital
DublinSeed–Growth$1.1M – $16.2M
11 people
Crossbeam Venture Partners
New YorkPre-Seed–Late Stage$1M – $1.5M
8 people
Green Sands Equity
San FranciscoSeries A–Late Stage
13 people
Heliad AG
Frankfurt am MainPre-Seed–Late Stage$5.4M – $16.2M
14 people
Sodero
NantesSeed–Late Stage$162K – $5.4M
19 people
C5 Capital
LondonSeries A–Growth
16 people
Velvet Sea Ventures
West Palm BeachSeed–Growth
10 people
Key1 Capital
HerzliyaSeries B–Late Stage
17 people
Stateless Ventures
San FranciscoPre-Seed–Late Stage
8 people
Champel Capital
JerusalemSeed–Late Stage
14 people
Coinvest Capital
VilniusPre-Seed–Growth$55K – $580K
9 people
Infinite Capital
West Palm BeachPre-Seed–Late Stage
7 people
Holtzbrinck Ventures
EuropeSeed–Late Stage
6 people
Fine Structures Ventures
CambridgePre-Seed–Late Stage
10 people
Koru Capital
Seed–Late Stage
2 people
Chenel Capital Partners
New YorkSeed–Late Stage
14 people
Inflection Ventures
New YorkSeries A–Late Stage
14 people
Marlinspike Partners
ArlingtonSeed–Late Stage
14 people
Transform Investments
Pre-Seed–Growth
2 people
Wallonie Entreprendre
LiègePre-Seed–Growth
9 people
What If Ventures
FriscoPre-Seed–Late Stage
3 people
Related lists
Series C Investors & VC Firms (1709)Series C Investors & VC Firms in North America (942)Series C Investors & VC Firms in United States (826)Defense Tech Investors & VC Firms (664)Series C Investors & VC Firms in Global (662)Series C Investors & VC Firms in Europe (661)Healthtech Series C Investors & VC Firms (564)SaaS Series C Investors & VC Firms (557)Fintech Series C Investors & VC Firms (535)Series C Investors & VC Firms in Asia-Pacific (533)
Data sourced from public filings and firms' own websites — see our methodology.































































































